Actively Recruiting
Development of a FibroScan Liver Examination Using a Single Probe
Led by Echosens · Updated on 2026-02-10
309
Participants Needed
4
Research Sites
58 weeks
Total Duration
On this page
Sponsors
E
Echosens
Lead Sponsor
N
Novotech CRO
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an exploratory, international, prospective, interventional, multicenter clinical investigation that will take place in 1 Hong Kong site and 3 French sites and 309 adults patients will be included. The study objective is to assess the LSM reproducibility between the FibroScan examination performed with the Single Probe (SP) and the FibroScan examination performed with the reference probes (M and XL).
CONDITIONS
Official Title
Development of a FibroScan Liver Examination Using a Single Probe
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥ 18 years of age)
- Patient followed with a chronic liver disease
- Adult patient able to give his written consent
- For European sites: patient affiliated to the healthcare system
You will not qualify if you...
- Vulnerable patients
- Patients with ascites
- Patients with heart failure
- Patients with acute hepatitis
- Patients with biliary obstruction
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
CHRU de Besançon
Besançon, France, 25000
Not Yet Recruiting
2
Hôpital St Eloi- CHU Montpellier
Montpellier, France, 34090
Not Yet Recruiting
3
Hôpital Paris Saclay
Orsay, France, 91400
Not Yet Recruiting
4
Prince of Wales Hospital the Chinese University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
A
Anne Llorca
CONTACT
L
Laura Cantu Sanchez
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here